0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology

Buy Now

Peritoneal Carcinomatosis: Drugs and Diseases (Hardcover, 1996 ed.) Loot Price: R5,496
Discovery Miles 54 960
Peritoneal Carcinomatosis: Drugs and Diseases (Hardcover, 1996 ed.): Paul H. Sugarbaker

Peritoneal Carcinomatosis: Drugs and Diseases (Hardcover, 1996 ed.)

Paul H. Sugarbaker

Series: Cancer Treatment and Research, 81

 (sign in to rate)
Loot Price R5,496 Discovery Miles 54 960 | Repayment Terms: R515 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

Peritoneal carcinomatosis dominates the clinical picture of many patients with gastrointestinal, gynecological and urological cancers. For many of them its dev astating effects contribute directly to their death. Most clinicians consider peritoneal carcinomatosis an incurable metastatic disease and give palliative treatment, re stricted to limited surgery and systemic chemotherapy. Contrary to this view, Paul Sugarbaker and his collegues base their approach on the concept that peritoneal carcinomatosis represents regional tumor spread, similar in its impact on treatment and prognosis to that of lymph node metastases in other malignancies. This concept emphasises the value of regional tumor control, as a potentially curative measure. In this book the combination of aggressive cytoreduction and intraperitoneal chemotherapy to control peritoneal carcinomatosis is extensively explored. Basic to this approach is the observation that most cancer cells show only relative resistence against commonly available drugs, which can be overcome by a sufficient increase of drug concentrations in tumor tissue. After intraperitoneal delivery, drugs will reach high tissue concentrations in the superficial few cell layers, while plasma concentrations will remain below toxic levels. Patients with only limited residual tumor at the peritoneal surface after cytoreduction may therefore benefit from intraperitoneal chemotherapy.

General

Imprint: Springer
Country of origin: Netherlands
Series: Cancer Treatment and Research, 81
Release date: 2001
First published: February 1996
Editors: Paul H. Sugarbaker
Dimensions: 235 x 155 x 18mm (L x W x T)
Format: Hardcover
Pages: 288
Edition: 1996 ed.
ISBN-13: 978-0-7923-3726-3
Categories: Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > General
LSN: 0-7923-3726-3
Barcode: 9780792337263

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners